Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Clin Immunol. 2009 Jun 28;132(3):321–333. doi: 10.1016/j.clim.2009.05.018

Figure 3.

Figure 3

Reductions in the percentages of liver NKT cells (CD1d tetramer+TCRαβ+) and increases in the concentrations of serum IL-4 and IFN-γ after administration of single doses of galactosylceramides into NZB/W or C57BL/6 mice. Bars in upper panels show the mean (±SD) percentages of NKT cells in untreated control mice or 24 hours after injections in experimental mice. Bars in lower panels show mean serum concentrations of IL-4 and IFN-γ 2 and 24 hours after injections respectively. There were 4 to 6 mice in each group for each dose. ND-not detectable. A, shows results in C57BL/6 mice and B shows results in NZB/W mice at age 12 weeks. None-untreated mice, α-C26-0.1μg, i.p., α-GalCer (C26); α-C8-20μg, i.p., α-GalCer (C8); β-C12-50μg, i.p., β-GalCer (C12); β-C12*-800μg, oral, β-GalCer (C12).